Provided is a multi-target compound with anticoagulation and platelet GPIIb/IIIa receptor antagonism. The formula of the multi-target compound is as follows: A-L-B-L'-C. A and B are binding sites with a thrombin, C is a binding site with a platelet GPIIb/IIIa receptor, L is a first linking group, and L' is a second linking group. Also provided are a preparation method for the compound and use of the compound. The compound has the effects on inhibiting human thrombin activity and a platelet GPIIb/IIIa receptor in vitro, and has the effects on antiplatelet aggregation in vitro/in vivo, and anticoagulation and antithrombosis in vivo.
本文提供了一种具有抗凝和血小板 G
PIIb/IIIa 受体拮抗作用的多靶点化合物。该多靶点化合物的分子式如下:A-L-B-L'-C。A和B是与凝血酶的结合位点,C是与血小板G
PIIb/IIIa受体的结合位点,L是第一连接基团,L'是第二连接基团。此外,还提供了该化合物的制备方法和用途。该化合物在体外具有抑制人凝血酶活性和血小板 G
PIIb/IIIa 受体的作用,在体外/体内具有抗血小板聚集的作用,在体内具有抗凝血和抗血栓形成的作用。